cbdMD, Inc. Common Stock (YCBD)
Basic Materials › Perfumes, Cosmetics & Other Toilet Preparations
Price History
Feb 9, 2026 — May 24, 2026Investment Snapshot
- P/B of 0.86 — trading below book value
- Piotroski F-Score 3/9 — signs of financial weakness
- Loss-making — negative ROE of -26.5%
cbdMD, Inc. Common Stock (YCBD) is a Basic Materials company operating in Perfumes, Cosmetics & Other Toilet Preparations, listed on the AMEX , with a market capitalisation of $8 million . Key value metrics: P/B ratio 0.86, Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
cbdMD, Inc. Common Stock — Fundamental Analysis Summary
On financial health, YCBD shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and negative return on equity of -26.5% (sector average: -1.2%), and manageable leverage with a debt-to-equity ratio of 0.31.
StockPik's composite Value Score for YCBD is 65/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
YCBD reports a high gross margin of 60.2% (sector average: 33.0%) and a negative operating margin of -12.4%.
YCBD shows revenue declining at 1% year-over-year, with earnings growing at 45%.